Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
Lilin Wang, … , Amy Bloom, Adrian Bot
Lilin Wang, … , Amy Bloom, Adrian Bot
Published October 15, 2002
Citation Information: J Clin Invest. 2002;110(8):1175-1184. https://doi.org/10.1172/JCI15536.
View: Text | PDF
Article Immunology

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination

  • Text
  • PDF
Abstract

Research Article

Authors

Lilin Wang, Dan Smith, Simona Bot, Luis Dellamary, Amy Bloom, Adrian Bot

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
The “danger-signal” quality of dsRNA motifs. (a and b) dsRNAs prevent hi...
The “danger-signal” quality of dsRNA motifs. (a and b) dsRNAs prevent high-zone tolerance. C57BL/6 mice (a) or LPS-resistant C3H/HeJ mice (b) were injected with a tolerogenic dose of hIgG alone or together with pI:pC or pA:pU. Mice were subsequently boosted with an immunogenic dose of hIgG in CFA. The antibodies against hIgG were measured by ELISA at various intervals, as shown in the figure. As control, we included mice immunized with hIgG emulsified in CFA and represented the maximal titer on the graph (dashed line). Results are shown as mean ± SEM of endpoint titers (n = 5/group). Similar results were obtained in LPS-responsive mice (not shown). (c and d) dsRNA motifs display differential ability to mobilize immunity against influenza virus. C57BL/6 (c) or C3H/HeJ (d) mice were treated with pI:pC, pA:pU, or PBS 1 day before and 1 day after pulmonary infection with influenza virus. On day 5, the virus titer in the pulmonary tissue was estimated and represented as TCID50/organ (mean ± SEM, n = 6/group). Results are representative of studies in TLR4–/– and competent mice. (e) Schematic depiction of the involvement of dsRNA danger motifs in the regulation of immunity: detection of dsRNA motifs triggers a “master switch” for B and T cell responses to coexisting antigens. In the absence of danger signals, the magnitude of immunity is low if the antigen is limiting (immune ignorance), or immune tolerance develops if antigen is abundant.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts